Fund Holdings — SECTORAL ASSET MANAGEMENT INC

Total Portfolio Value:
$120.73M
Total Bought:
$13.23M
Total Sold:
$19.56M
Net Transaction:
-$6.33M
Notable People:
Jerome Georges Pfund
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Evommune, Inc.(EVMN)589,005589,0050$10.08M$13.54M11.22%+$3.46M
Contineum Therapeutics, Inc.CL A(CTNM)800,787727,587-73,200$9.15M$9.50M7.87%+$349.3K
Shoulder Innovations, Inc.(SI)492,435430,407-62,028$7.04M$6.25M5.18%-$788.0K
Eli Lilly and Company(LLY)7,2766,354-922$7.82M$5.84M4.84%-$1.98M
Johnson & Johnson(JNJ)20,30018,218-2,082$4.20M$4.45M3.69%+$252.1K
Gilead Sciences, Inc.(GILD)17,88527,490+9,605$2.20M$4.13M3.42%+$1.94M
UnitedHealth Group Incorporated(UNH)13,59514,957+1,362$4.49M$4.05M3.35%-$440.6K
Amgen Inc.(AMGN)13,0709,210-3,860$4.28M$3.51M2.91%-$763.0K
Vertex Pharmaceuticals Incorporated(VRTX)8,0057,007-998$3.63M$3.46M2.86%-$172.0K
Insmed Incorporated(INSM)11,18219,668+8,486$1.95M$3.38M2.80%+$1.43M
argenx SEADR(ARGX)2,8943,564+670$2.43M$2.74M2.27%+$303.3K
AbbVie Inc.(ABBV)16,80012,200-4,600$3.84M$2.65M2.20%-$1.19M
Abbott Labs23,49825,578+2,080$2.94M$2.63M2.18%-$318.0K
Merck & Co., Inc.(MRK)21,40021,480+80$2.25M$2.58M2.14%+$331.3K
Regeneron Pharmaceuticals, Inc.(REGN)3,7152,919-796$2.87M$2.48M2.06%-$385.8K
Intuitive Surgical, Inc.(ISRG)4,8505,250+400$2.75M$2.42M2.00%-$326.6K
Boston Scientific Corporation(BSX)27,62634,780+7,154$2.63M$2.18M1.81%-$451.7K
BioNTech SEADR(BNTX)17,21822,164+4,946$1.64M$2.05M1.69%+$406.2K
Stryker Corporation(SYK)6,5505,874-676$2.30M$1.93M1.60%-$372.0K
Danaher Corporation(DHR)10,5759,597-978$2.42M$1.82M1.51%-$601.2K
Thermo Fisher Scientific Inc.(TMO)3,9003,508-392$2.26M$1.72M1.43%-$535.6K
DexCom, Inc.(DXCM)28,70023,231-5,469$1.90M$1.46M1.21%-$445.9K
IQVIA Holdings Inc.(IQV)08,307+8,307$0$1.42M1.17%+$1.42M
Summit Therapeutics Inc.(SMMT)79,62569,615-10,010$1.39M$1.40M1.16%+$7.0K
Edwards Lifesciences17,25017,338+88$1.47M$1.39M1.15%-$82.1K
Bristol-Myers Squibb Company(BMY)021,150+21,150$0$1.28M1.06%+$1.28M
United Therapeutics Corporation(UTHR)1,7231,710-13$839.5K$1.15M0.95%+$306.1K
Vera Therapeutics, Inc.CL A(VERA)36,85825,573-11,285$1.87M$1.08M0.90%-$781.8K
Arcus Biosciences, Inc.(RCUS)56,94545,070-11,875$1.36M$1.04M0.86%-$321.5K
Roivant Sciences Ltd.SHS(ROIV)45,34732,500-12,847$984.0K$1.02M0.84%+$32.3K
Medtronic plcSHS(MDT)011,100+11,100$0$961.8K0.80%+$961.8K
Trevi Therapeutics, Inc.(TRVI)84,25574,446-9,809$1.05M$939.5K0.78%-$115.4K
Cogent Biosciences, Inc.(COGT)32,68522,140-10,545$1.16M$902.4K0.75%-$258.6K
Mineralys Therapeutics, Inc.(MLYS)31,62531,618-7$1.15M$895.1K0.74%-$252.5K
Alnylam Pharmaceuticals, Inc.(ALNY)2,9902,310-680$1.19M$864.2K0.72%-$324.7K
Tarsus Pharmaceuticals, Inc.(TARS)14,74011,272-3,468$1.21M$852.5K0.71%-$354.4K
Rapport Therapeutics, Inc.(RAPP)38,92525,421-13,504$1.18M$835.0K0.69%-$346.0K
Nektar Therapeutics(NKTR)13,48510,851-2,634$570.1K$820.7K0.68%+$250.5K
Syndax Pharmaceuticals, Inc.(SNDX)61,20031,680-29,520$1.29M$787.5K0.65%-$498.3K
Ardelyx Inc0122,394+122,394$0$781.1K0.65%+$781.1K
Pfizer Inc.(PFE)27,15027,500+350$676.0K$772.2K0.64%+$96.2K
Boundless Bio, Inc.(BOLD)678,574678,5740$814.3K$746.4K0.62%-$67.9K
Ascendis Pharma A/SADR(ASND)3,2542,800-454$693.9K$728.3K0.60%+$34.4K
ArriVent BioPharma, Inc.(AVBP)38,25530,013-8,242$769.7K$720.4K0.60%-$49.3K
Structure TherapeuticsADR23,87214,102-9,770$1.66M$710.8K0.59%-$949.5K
Immatics N.V.SHS(IMTX)63,01566,830+3,815$661.7K$692.7K0.57%+$31.0K
BridgeBio Pharma, Inc.(BBIO)11,1708,100-3,070$854.4K$687.3K0.57%-$167.1K
ARS Pharmaceuticals, Inc.(SPRY)29,80379,150+49,347$347.2K$676.7K0.56%+$329.5K
BeOne Medicines AGADR(ONC)2,6651,870-795$809.7K$631.1K0.52%-$178.6K
Tectonic Therapeutic, Inc.(TECX)42,25519,059-23,196$881.4K$628.2K0.52%-$253.2K
Ionis Pharmaceuticals, Inc.(IONS)8,3657,200-1,165$661.8K$617.2K0.51%-$44.5K
BioMarin Pharmaceutical Inc.(BMRN)10,8809,450-1,430$646.6K$607.3K0.50%-$39.3K
Kura Oncology, Inc.(KURA)54,11071,480+17,370$562.2K$606.0K0.50%+$43.8K
Privia Health Group, Inc.(PRVA)26,00027,136+1,136$616.5K$558.2K0.46%-$58.3K
Cytokinetics, Incorporated(CYTK)5,8937,300+1,407$374.4K$544.6K0.45%+$170.2K
PTC Therapeutics, Inc.(PTCT)7,7156,650-1,065$586.0K$515.1K0.43%-$71.0K
uniQure N.V.SHS(QURE)30,58529,245-1,340$731.9K$499.4K0.41%-$232.5K
AgomAb Therapeutics NVADS(AGMB)043,500+43,500$0$477.3K0.40%+$477.3K
Alignment Healthcare, Inc.(ALHC)31,50026,911-4,589$622.1K$474.2K0.39%-$148.0K
Hinge Health, Inc.CL A(HNGE)14,20612,244-1,962$659.9K$472.1K0.39%-$187.7K
RadNet, Inc.(RDNT)11,0007,999-3,001$784.9K$447.1K0.37%-$337.8K
Royalty Pharma plcCL A(RPRX)8,4707,200-1,270$327.3K$393.8K0.33%+$66.6K
Biogen Inc.(BIIB)2,1551,850-305$379.3K$385.9K0.32%+$6.7K
Inspire Medical Systems, Inc.(INSP)7,2007,225+25$664.1K$372.7K0.31%-$291.4K
Jazz Pharmaceuticals plcSHS USD(JAZZ)2,0491,750-299$348.3K$371.3K0.31%+$23.0K
Neurocrine Biosciences, Inc.(NBIX)2,6752,300-375$379.4K$343.8K0.28%-$35.6K
ORIC Pharmaceuticals, Inc.(ORIC)22,48023,500+1,020$183.9K$332.7K0.28%+$148.8K
Omada Health, Inc.(OMDA)36,50025,620-10,880$576.0K$322.0K0.27%-$253.9K
ABIVAX Société AnonymeADS(ABVX)02,340+2,340$0$297.9K0.25%+$297.9K
Illumina, Inc.(ILMN)2,4722,132-340$324.2K$296.1K0.25%-$28.2K
Axsome Therapeutics, Inc.(AXSM)1,7401,500-240$317.8K$289.9K0.24%-$27.9K
Incyte Corporation(INCY)2,7502,350-400$271.6K$254.1K0.21%-$17.5K
Moderna, Inc.(MRNA)5,0054,350-655$147.6K$247.9K0.21%+$100.3K
Medpace Holdings, Inc.(MEDP)0430+430$0$228.1K0.19%+$228.1K
Guardant Health, Inc.(GH)01,980+1,980$0$205.5K0.17%+$205.5K
Revolution Medicines, Inc.(RVMD)01,830+1,830$0$202.3K0.17%+$202.3K
Palisade Bio, Inc.(PALI)088,000+88,000$0$172.4K0.14%+$172.4K
Amicus Therapeutics
COM
43,3000-43,300$616.6K$0—-$616.6K
AstraZeneca PLCADR(AZN)15,2320-15,232$1.40M$0—-$1.40M
Carlsmed, Inc.(CARL)47,7000-47,700$589.1K$0—-$589.1K
LENZ Therapeutics, Inc.(LENZ)42,5000-42,500$680.0K$0—-$680.0K
Madrigal Pharmaceuticals, Inc.(MDGL)3520-352$205.0K$0—-$205.0K
Tempus AI, Inc.CL A(TEM)4,5000-4,500$265.7K$0—-$265.7K
Ventyx Biosciences96,9450-96,945$875.4K$0—-$875.4K
Page 1 of 1
SECTORAL ASSET MANAGEMENT INC — 13F Holdings — Q1 2026 | TickerTrail